Wholesale of Pharmaceutical Products
Industry Group (4331)
2024-Q2: $3.31T MX, Gross Domestic Product
DENUE May 2025: 1,876, Economic units
Jan-Sep 2024: US$84.9M, Foreign Direct Investment
In the second quarter of 2024 the gross domestic product was $3.31T MX, 1.62% more than the previous quarter.
According DENUE 2025, Wholesale of Pharmaceutical Products registered 1,876 economic units. The states with the highest number of economic units were Ciudad de México (284), Estado de México (246), and Jalisco (158).
According to data from the Economic Census 2019, total gross production was $46.5B MX. The states with the highest total gross production were Ciudad de México ($24B MX) and Estado de México ($3.7B MX).
For its part, total income reached $160B MX in 2019, being the states with the highest income Ciudad de México ($70.3B MX) and Estado de México ($13.5B MX).
Economic activities are related if they require similar knowledge or inputs. In 2014 in Wholesale of Pharmaceutical Products the states with the highest affinity were Nuevo León (0.77), Chihuahua (0.74), Baja California (0.7), Querétaro (0.69), and Sonora (0.69).
Production
#permalink to sectionGross Domestic Product
#permalink to sectionGross domestic product 2024-Q2: $3.31T MX
Gross Domestic Product 2023: $3.17T MX
* Data displayed corresponds to the sector Wholesale Trade since the information at lower levels of disaggregation is not available.
In the second quarter of 2024, Wholesale Trade recorded a gross domestic product of $3.31T MX, evidencing an increase of 1.62% compared to the previous quarter and an increase of 8.16% compared to the same period of the previous year.
* Current values, at current prices, base year 2013. Excludes taxes on products.
Production Indicators by State
#permalink to sectionAccording to data from the Economic Census 2019, 1,821 economic units were totaled in Wholesale of Pharmaceutical Products, highlighting Ciudad de México (343), Estado de México (189), and Jalisco (175).
Total gross production was $46.5B MX. The states with the highest total gross production were Ciudad de México ($24B MX) and Estado de México ($3.7B MX).
Total income reached $160B MX in 2019, being the states with the highest income Ciudad de México ($70.3B MX) and Estado de México ($13.5B MX).
* It is recommended to consider the values as approximations of the real value because some records have been anonymized due to confidentiality principles.
Production Indicators by Municipality
#permalink to sectionAccording to dato from Economic Census 2014, Wholesale of Pharmaceutical Products had a total of 4,686 economic units and the municipalities with the highest number of economic units were Guadalajara (327), Monterrey (186), and Cuauhtémoc (159)
Total income eached $315B MX and the municipalities with the highest income were Coyoacán ($32.5B MX), Cuauhtémoc ($31.7B MX), and Ecatepec de Morelos ($24.8B MX).
Total expenditures were $269B MX and the municipalities with the highest expenditures were Coyoacán ($28.4B MX), Cuauhtémoc ($24.6B MX), and León ($17.5B MX).
On the other hand, in 2014 there were 54978 employees dependent on economic units and the municipalities with the highest number of employees were Guadalajara (5.59k), Benito Juárez (3.52k), and Iztapalapa (2.98k).
* Any inconsistency between the data at the state and municipal level is due to the anonymization methodologies applied to the data, also municipalities not shown in the visualization have been anonymized.
Economic Units
#permalink to sectionThe visualization shows the number of economic units in Wholesale of Pharmaceutical Products according to the number of employees.
According to DENUE data published in May 2025, 1,419 companies with 0 to 10 employees were registered (1,419 companies more than the previous period). In the same period, 277 companies with 11 to 50 employees were registered (277 companies more than the previous period).
56 companies with 51 to 100 employees were registered in 2025 (56 companies more than the previous period). Likewise, 124 companies with more than 101 employees were registered (124 companies more than the previous period).
Source National Statistical Directory of Economic Units (DENUE)
Investment
#permalink to sectionForeign Direct Investment (FDI)
#permalink to section- US$84.9M, FDI Jan-Sep 2024
- US$1.29B, FDI Jan-1999 to Sep-2024
In the period January to September 2024, FDI from Wholesale of Pharmaceutical Products was US$84.9M, distributed in reinvestment of earnings (US$46.1M), inter-company debts (US$38.8M), and equity Capital (Confidential).
Since January 1999 to September 2024, the accumulated amount of FDI in Wholesale of Pharmaceutical Products was US$1.29B, distributed in equity Capital (US$510M), inter-company debts (US$497M), and reinvestment of earnings (US$285M).
* Confidential data is not shown in the chart (see information icon in the section).
Foreign Direct Investment (FDI) by State
#permalink to sectionPeriod Jan-Sep 2024: US$0
Period Jan-1999 to Sep-2024: US$521M, Mexico City is the main receiving state
No FDI is recorded in the period January to September, 2024
Historically (from January 1999 to September2024) the states that have received the highest FDI are Mexico City (US$521M), Estado de México (US$398M), and Chihuahua (US$132M).
* Information download does not contain confidential data.
Foreign Direct Investment (FDI) Origin
#permalink to sectionPeriodo Jan-Sep 2024: ---, US$0
Main investing country between Jan-1999 and Sep-2024: United States, US$494M
No FDI is recorded in the period January to September of 2024.
Historically (from January 1999 to September de 2024) the countries that contributed the most to FDI were Germany (US$44.4M), United States (US$16.5M), and Denmark (Confidential).
* Information download does not contain confidential data.
Specialization and Opportunity
#permalink to sectionThe states with the highest degree of development opportunity in Wholesale of Pharmaceutical Products according to Relatedness were Coahuila de Zaragoza (0.68), Colima (0.51), and San Luis Potosí (0.51). The Relatedness measures the distance between an industry and the current industrial composition in each state. The presented entities register a level of specialization lower than one unit (RCA <1).